[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346782-105":59,"doc-detail-346782-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-impact-of-the-covid-19-pandemic-on-breast-cancer-screening-treatment-and-overall-survival","The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival","","Examines how the COVID-19 pandemic affected breast cancer screening, treatment, and 2-year overall survival for individuals diagnosed with breast cancer in Manitoba, Canada. Uses population-based data with a quasi-experimental interrupted time series design to compare screening mammograms, first treatment rates, and 2-year survival before versus after COVID-19. Finds substantial reductions in screening mammograms and several treatment components, while overall survival remained unchanged.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-impact-of-the-covid-19-pandemic-on-breast-cancer-screening-treatment-and-overall-survival/346782/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-impact-of-the-covid-19-pandemic-on-breast-cancer-screening-treatment-and-overall-survival/346782.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s primary objective regarding COVID-19 and breast cancer in Manitoba?","Question",{"text":113,"@type":114},"To examine the association between the COVID-19 pandemic and breast cancer screening, treatment, and 2-year overall survival for individuals diagnosed with breast cancer in Manitoba, Canada.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the researchers evaluate changes over the course of the pandemic?",{"text":118,"@type":114},"They used population-based data and a quasi-experimental interrupted time series analysis to assess screening mammograms, first treatment rates, and 2-year overall survival before and after COVID-19.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the main findings about screening and treatment during the pandemic?",{"text":122,"@type":114},"Screening mammograms decreased significantly about two years after the pandemic began, and multiple treatment components (e.g., surgery, radiotherapy, hormone therapy) showed reductions, while some neoadjuvant and targeted therapy proportions increased for certain subtypes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346782,1790167360,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Breast Cancer Research and Treatment (2026) 217:7 [https://doi.org/10.1007/s10549-026-07943-3](https://doi.org/10.1007/s10549-026-07943-3)  \nThe impact of the COVID‑19 pandemic on breast cancer screening, treatment, and overall survival  \nKathleen M. Decker1,2,3 · Allison Feely2 · Marshall Pitz1,3,4,5 · Pamela Hebbard6 · Julian O. Kim1,7,8 · Piotr Czaykowski3,4,5 · Harminder Singh1,3,4 · Oliver Bucher2 · Grace Musto2 · Pascal Lambert1,2  \nReceived: 20 January 2026 / Accepted: 11 March 2026 / Published online: 31 March 2026 © The Author(s) 2026  \nAbstract  \nPurpose We examined the association between the COVID-19 pandemic and screening, treatment, and overall survival for individuals diagnosed with breast cancer in Manitoba, Canada.  \nMethods We used population-based data and a quasi-experimental study with an interrupted time series analysis to examine the number of screening mammograms, first treatment rates, and 2-year overall survival prior to and after COVID-19 for individuals diagnosed with breast cancer.  \nResults There was a significant decrease in screening mammograms 2 years after the start of the pandemic (ratio = 0.73%, 95% Confidence Interval (CI) 0.58, 0.89). From April to June 2020, fewer individuals diagnosed with stage I–III breast cancer had surgery (ratio = 0.59, 95% CI 0.33, 1.07) . Fewer individuals diagnosed with stage I–III breast cancer had radiotherapy (RT) (ratio = 0.69, 95% CI 0.53, 0.91). RT factions per person-year were lower (ratio = 0.81, 95% CI 0.71, 0.92, April to June 2020 and 0.60, 95% CI 0.56, 0.66, July 2020 to December 2022). The proportion of individuals with stage I–III ER+ /HER2-breast cancer who had hormone therapy (HT) was lower (ratio = 0.55, 95% CI 0.36, 0.84). The proportion of individuals with stage I–III HER2+ breast cancer who had neoadjuvant chemotherapy (ratio = 3.64, 95% CI 1.18, 11.16) or targeted therapy (ratio = 3.34, 95% CI 1.13, 9.84) was higher. The proportion of individuals who had adjuvant chemotherapy (ratio = 0.14, 95% CI 0.04, 0.47, April to June 2020 and ratio = 0.19, 95% CI 0.08, 0.48, January to December 2022), targeted therapy (ratio = 0.14, 95% CI 0.04, 0.45, April to June 2020 and ratio = 0.18, 95% CI 0.07, 0.45 January to December 2022), or HT (ratio = 0.43, 95% CI 0.22, 0.83) was lower. The proportion of individuals with stage I–III triple-negative breast cancer who had neoadjuvant chemotherapy was higher (ratio = 2.92, 95% CI 1.04, 8.17) . There was no difference for any treatment for stage IV breast cancers. There was no difference in 2-year overall survival for stage I–III or stage IV breast cancers. Conclusion In Manitoba, Canada, there was a significant decrease in the number of screening mammograms 2 years after the start of the pandemic. Breast cancer treatment changed in accordance with updated guidelines with no impact on 2-year overall survival.  \nKeywords Neoplasms · Treatment · COVID-19 · Interrupted time series analysis · Epidemiology · Canada  \nIntroduction  \nDuring the COVID-19 pandemic, the health care system faced many unprecedented challenges. These challenges necessitated changes in clinical protocols and patient workflows to help protect patients and health care staff from exposure to COVID-19 and ensure that care could be provided to those that were affected by COVID-19 . The cancer care system also implemented changes including the greater use of virtual visits, the temporary suspension or reduction of  \nExtended author information available on the last page of the article  \ncancer screening and diagnostic services, triaging patients for treatment based on acuity, and the redeployment of health care staff to process COVID-19 tests and care for acute cases of COVID-19 .  \nOne topic that caused anxiety among health care providers, patients, and the public was the potential negative impact of COVID-19 on breast cancer [1] . Studies estimated that delays in diagnosing and treating breast cancer would lead to increases in the number of advan","cbCaigm0N24fGHxD","https://ap.wps.com/l/cbCaigm0N24fGHxD","pdf",3172302,15,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Methods\n## Setting","[{\"question\":\"What was the study’s primary objective regarding COVID-19 and breast cancer in Manitoba?\",\"answer\":\"To examine the association between the COVID-19 pandemic and breast cancer screening, treatment, and 2-year overall survival for individuals diagnosed with breast cancer in Manitoba, Canada.\"},{\"question\":\"How did the researchers evaluate changes over the course of the pandemic?\",\"answer\":\"They used population-based data and a quasi-experimental interrupted time series analysis to assess screening mammograms, first treatment rates, and 2-year overall survival before and after COVID-19.\"},{\"question\":\"What were the main findings about screening and treatment during the pandemic?\",\"answer\":\"Screening mammograms decreased significantly about two years after the pandemic began, and multiple treatment components (e.g., surgery, radiotherapy, hormone therapy) showed reductions, while some neoadjuvant and targeted therapy proportions increased for certain subtypes.\"}]","The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival | PDF",1790062735,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b5e432d28d832b5fcfa6db6504bfef0.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c66b603bef9540389c63cb782be38ff8.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f723033a9f1142ee144400150025dbad.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98b1295a660c4d3f03a55f1c53f0b3ec.webp",980,1301]